Mizuho Initiates Coverage On Cabaletta Bio with Buy Rating, Announces Price Target of $22

Benzinga | Jun 30, 2021 5:06 AM EDT

Mizuho Initiates Coverage On Cabaletta Bio with Buy Rating, Announces Price Target of $22

Mizuho analyst Vamil Divan initiates coverage on Cabaletta Bio (NASDAQ:CABA) with a Buy rating and announces Price Target of $22.